*apoya mal la mano en un sillón, se luxa un pulgar*

Join us on Tues Sept 30 @ 12 pm EDT to discuss the CHALLENGE trial: Structured Exercise after Adjuvant Chemotherapy for Colon Cancer with authors Dr. Christopher Booth & Dr. Fernanda Arthuso! Register: tinyurl.com/462jujzu #CommonSenseOncology #CancerCare CCTG

Will you join the inaugural webinar of the new Common Sense Oncology India Hub? We invite those from India and beyond to join us on Wednesday, September 17, at 7:00 pm IST to learn more about CSO and discuss a critical appraisal of the MATTERHORN trial. Register here on Zoom:

📖 Looking for a good weekend read? Check out the new ASCO Global Geriatric Oncology Guidelines #gerionc #globonc. They provide practical, resource-stratified recommendations to improve care for older adults with cancer worldwide. 🌍👵👴 🔗 doi.org/10.1200/GO-25-…

"The hike is complete but the trail is still there; it needs hikers to be complete." Daniel Wolfson on the #ChoosingWisely program sunsetting and who will take up the banner to improve value in healthcare. The onus is on us. The trail awaits. 👣🛤️⛰️

Join us at ESMO Congress 2025 Berlin for a Common Sense Oncology Common Sense Oncology symposium! Dario Trapani WinetteVanDerGraaf Chris Cronin Madelline Pe Chris Booth

Had a wonderful day brainstorming on the future steps for Costs of Care with these healthcare visionaries. Thank you to Vinny Arora MD MAPP for hosting us UChicago Pritzker School of Medicine on the phenomenally beautiful The University of Chicago campus.

No sirve el semáforo de Calzada de Tlalpan esquina con Miguel Hidalgo dirección norte desde el lunes. Alcaldía Tlalpan Tlalpan Vecinos

Our recommendations to improve access thru dose optimization and substitutions of expensive drugs ESMO - Eur. Oncology Gastrointestinal Oncology Journal Renata D'Alpino Daniel Goldstein MD Tiago Felismino Bettina Müller #costeffectiveness #colorectalcancer #PancreaticCancer sciencedirect.com/science/articl…

Feliz de ver las ideas de Common Sense Oncology en la conferencia magistral del Congreso Nacional de Oncología Sociedad Mexicana de Oncología, A.C.. Necesitamos trabajar en conjunto para que más pacientes puedan vivir más tiempo y con mejor calidad de vida. pic.x.com/cOvRRZDwbF

Muchas gracias a Sociedad Mexicana de Oncología, A.C. por la oportunidad de participar y coordinar el módulo de Oncogeriatría. Un honor contar con la valiosa contribución de nuestr@s ponentes Haydeé Verduzco, Enrique Soto y Paty Navarrete, quienes enriquecieron enormemente este espacio. #CongresoSMeO2025

El mismo problema que en México. Los estudiantes de medicina y residentes de medicina interna necesitan exposición al ambiente ambulatorio en oncología para conocer qué es lo que hacemos principalmente. Pero cuando hay escuelas de medicina que ni materia de onco tienen...

Se logró. Hora de mimir. Hagan changuitos por mí de aquí a abril 🐒

🚨 ESMO 2025 | LBA15 (AIIMS Delhi) 🧬 Low-dose Pembrolizumab in TNBC Phase II RCT: Pembrolizumab 50 mg q6wk × 3 + NACT vs NACT alone 👉 pCR 53.8% vs 40.5% (Δ 13.3%, p = 0.047) ➡️ Nearly matches KN-522 results at a fraction of the dose and cost. 💊 Grade ≥ 3 AEs: 50% vs 59.5%

Ya es hora de creer que las dosis bajas de inmuno sí funcionan.

* * * CONVOCATORIA * * * Posgrado de Alta Especialidad en Medicina Geriatría Oncológica Información: [email protected]

Mark your calendars for CSO's LGCW webinar on Nov 24th! Hear from our Working Group Leaders, Drs. Ian Tannock, Haydeé Verduzco-Aguirre, Brooke Wilson, Michelle Tregear, & Christopher Jackson about CSO’s exciting work & learn how to get involved. tinyurl.com/3r9xdrx4

Now THAT is a prescribing cascade Carolyn Tan

Curious about how to make geriatric assessment work in real-world oncology practice, especially when resources are limited? Check out this companion paper breaking down practical insights from the ASCO Global Geriatric Assessment Guideline: ascopubs.org/doi/10.1200/GO… #gerionc

Chemotherapy saves lives, but not always. Side effects, from common to infrequent but potentially life-threatening remain a concern for patients and prescribers across the 🌎 What if a single blood tube could predict who will benefit and who won’t? insight.jci.org/articles/view/…